Back to Search
TAYLOR CLEMENS, DO
DO
General Practice Physician
NPI: 1346741592Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Estradiol and tamoxifen mediate rescue of the dominant-negative effects of estrogen response element-binding protein in vivo and in vitro.
PMID 19106221·Endocrinology·2009
7-preclinical
Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation.
PMID 19257813·J Bone Miner Res·2009
7-preclinical
Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.
PMID 19338032·J Orthop Res·2009
7-preclinical
Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling.
PMID 19415227·J Mol Med (Berl)·2009
6-review
Mineralization and bone resorption are regulated by the androgen receptor in male mice.
PMID 19049333·J Bone Miner Res·2009
7-preclinical
Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.
PMID 19460757·J Biol Chem·2009
7-preclinical
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling.
PMID 18378684·J Biol Chem·2008
7-preclinical
Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration.
PMID 18184809·Proc Natl Acad Sci U S A·2008
7-preclinical
Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion.
PMID 18593713·J Biol Chem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 354 Alexander Spring Rd Ste 3
Carlisle, PA 17015 - Phone
- (717) 462-6873
Quick Facts
- NPI
- 1346741592
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile